AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL

NEUTRAL Impact: 2/10 6-K
Horizon immediate Filed May 28, 2026 Processed 12d 21h ago SEC 0001213900-26-062191
Notable filing: 6-K
Latest settled — T+5d ⚠ clustered
AAPG ▼ -14.04% at T+5d
NEUTRAL call ✗ call lost -14.04% · α vs SPY -11.52% · entry $20.01 → $17.20
Next anchor: T+20d in 16d
Currently $17.07 · -14.69% from $20.01 entry
Entry anchored
May 28, 2026
via day open
T+1d
-4.65%
call -4.65% · α -4.91%
$19.08
settled 12d ago
T+5d
-14.04%
call -14.04% · α -11.52%
$17.20
settled 6d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Ascentage Pharma disclosed that its trustee purchased 50,000 existing shares on-market for HK$1,909,800 (HK$38.196/share) under the 2022 RSU scheme, representing ~0.0134% of total shares outstanding. This routine administrative action has no material impact on the company's operations or financials.

Actionable Insight

No market-moving implications. The purchase is a standard RSU settlement mechanism. Monitor upcoming clinical trial readouts or earnings for material catalysts.

Key Facts

  • Trustee purchased 50,000 shares on May 28, 2026 at average HK$38.196 per share
  • Total consideration HK$1,909,800
  • Total shares held by trustee post-purchase: 2,315,000
  • Purchase represents approximately 0.0134% of total issued shares

Financial Impact

HK$1.91 million share purchase, immaterial relative to market cap

shares outstanding

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (14 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-062191
Document: ea029265001-6k_ascentage.htm0001213900-26-062191
Document: 0001213900-26-062191-index-headers.html0001213900-26-062191
Document: 0001213900-26-062191-index.html0001213900-26-062191
Document: 0001213900-26-062191.txt0001213900-26-062191
16 reports for AAPG
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AAPG — sortable, filterable
Type Now
Jun 1, 2026
9d ago
6-K
NEUTRAL ★ 4/10
$19.08 $17.20▼ −9.85%▼ −7.10%$17.07 (−10.53%)
May 28, 2026
12d ago
6-K
NEUTRAL ★ 2/10
$20.01 $17.20▼ −14.04%▼ −11.52%$17.07 (−14.69%)
May 28, 2026
13d ago
6-K
NEUTRAL ★ 2/10
$19.88 $17.87▼ −10.11%▼ −10.06%$17.07 (−14.13%)
May 22, 2026
19d ago
6-K
NEUTRAL ★ 5/10
$21.01 $19.08▼ −9.19%▼ −10.86%$17.07 (−18.75%)
May 22, 2026
19d ago
Press Release
NEUTRAL ★ 4/10
$21.01 $19.08▼ −9.19%▼ −10.84%$17.07 (−18.75%)
May 13, 2026
28d ago
6-K
NEUTRAL ★ 3/10
$21.38 $18.99▼ −11.18%▼ −10.02%$17.07 (−20.16%)
May 12, 2026
29d ago
6-K
NEUTRAL ★ 2/10
$21.16 $18.56▼ −12.29%▼ −12.37%$17.07 (−19.33%)
Apr 22, 2026
7w ago
6-K
BULLISH ★ 7/10
$25.13 $22.75▼ −9.47%▼ −9.53%$17.07 (−32.07%)
Apr 22, 2026
7w ago
Press Release
BULLISH ★ 7/10
$25.13 $22.75▼ −9.47%▼ −9.53%$17.07 (−32.07%)
Apr 20, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$26.36 $23.37▼ −11.34%▼ −12.26%$17.07 (−35.24%)
Showing 10 of 16

US Market Status

Market Open — Closes in 1h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access